Chuck Triano | Senior Vice President-Investor Relations |
Albert Bourla | Chairman and Chief Executive Offier |
Frank D'Amelio | Chief Financial Officer |
Mikael Dolsten | President-Worldwide Research and Development |
Angela Hwang | Group President-Pfizer Biopharmaceuticals Group |
John Young | Chief Business Officer |
Doug Lankler | General Counsel |
Steve Scala | Cowen |
Tim Anderson | Wolfe Research |
Vamil Divan | Mizuho Securities |
Randall Stanicky | RBC Capital Markets |
Terence Flynn | Goldman Sachs |
Louise Chen | Cantor |
Chris Schott | JP Morgan |
Umer Raffat | Evercore |
David Risinger | Morgan Stanley |
Geoffrey Porges | SVB Leerink |
Good day, everyone, and welcome to Pfizer's Second Quarter 2020 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.